Source:http://linkedlifedata.com/resource/pubmed/id/15168777
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2004-5-31
|
pubmed:abstractText |
Lymphoepithelioma-like carcinoma (LELC) of the lung is an undifferentiated carcinoma with prominent lymphoid stroma. We encountered a case of synchronous primary lung cancers of LELC and papillary adenocarcinoma in a 67-year-old Japanese woman. By in situ hybridization, Epstein-Barr virus (EBV) genome was detected in malignant epithelial cells of LELC but not in the papillary adenocarcinoma. Tumor-infiltrating lymphocytes in LELC were predominantly CD8+ and T cell intracytoplasmic antigen (TIA-1)+ cytotoxic T cells with closely associated with HLA-DR-positive LELC cells by double immunostaining. These data indicate that the exaggerated lymphoid infiltration in and around the EBV-infected carcinoma cells may represent the enhanced tumor immunity, suggesting a better prognostic indicator.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0918-2918
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
323-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15168777-Adenocarcinoma, Papillary,
pubmed-meshheading:15168777-Aged,
pubmed-meshheading:15168777-Female,
pubmed-meshheading:15168777-Herpesvirus 4, Human,
pubmed-meshheading:15168777-Humans,
pubmed-meshheading:15168777-Immunohistochemistry,
pubmed-meshheading:15168777-In Situ Hybridization,
pubmed-meshheading:15168777-Lung Neoplasms,
pubmed-meshheading:15168777-Lymphocytes, Tumor-Infiltrating,
pubmed-meshheading:15168777-Neoplasms, Multiple Primary,
pubmed-meshheading:15168777-T-Lymphocytes, Cytotoxic
|
pubmed:year |
2004
|
pubmed:articleTitle |
Pulmonary lymphoepithelioma-like carcinoma: predominant infiltration of tumor-associated cytotoxic T lymphocytes might represent the enhanced tumor immunity.
|
pubmed:affiliation |
Department of Pathology, Shinshu University School of Medicine, Matsumoto.
|
pubmed:publicationType |
Journal Article,
Case Reports
|